C4 article: Implications of COVID-19 in transplantation

Am J Transplant. 2021 May;21(5):1801-1815. doi: 10.1111/ajt.16346. Epub 2020 Nov 6.


A novel coronavirus has had global impact on individual health and health care delivery. In this C4 article, contributors discuss various aspects of transplantation including donor and recipient screening, management of infected patients, and prevention of coronavirus disease (COVID). Donor screening with SARS-CoV-2 nucleic acid testing (NAT) close to the time of procurement is recommended. Many programs are also screening all potential recipients at the time of admission. The management of COVID has evolved with remdesivir emerging as a new potential option for transplant recipients. Dexamethasone has also shown promise and convalescent plasma is under study. Prevention strategies for transplant candidates and recipients are paramount. Pediatric-specific issues are also discussed. Strategies for the psychological well-being of patients and providers are also imperative, in addition to future research priorities for transplantation.

Keywords: clinical research/practice; infection and infectious agents; infection and infectious agents - viral; infectious disease; organ transplantation in general.

MeSH terms

  • COVID-19 / diagnosis*
  • COVID-19 Nucleic Acid Testing*
  • Child
  • Dexamethasone / therapeutic use
  • Humans
  • Organ Transplantation*
  • Tissue Donors*
  • Tissue and Organ Procurement*


  • Dexamethasone